Rapid Response
TOOLBOX
Filter
59
Featured
Language
Document type
Guidelines
28
Studies & Reports
7
Fact sheets
6
No document type
6
Resource Platforms
5
Strategic & Response Plan
3
Situation Updates
2
Training Material
1
Infographics
1
Countries / Regions
Nigeria
5
Germany
2
Mozambique
1
Global
1
Congo, Democratic Republic of
1
United Kingdom
1
South Africa
1
Brazil
1
Angola
1
Pakistan
1
Authors & Publishers
World Health Organization WHO
10
Africa Center for Disease Control and Prevention CDC
7
World Health Organisation (WHO)
6
Centers for Disease Control and Prevention (CDC)
4
et al.
3
Pan American Health Organisation PAHO
3
World Health Organization (WHO)
3
RKI
2
Robert Koch Institut (RKI)
2
The Lancet
2
Africa Center for Disease Control and Prevention
1
Aruna, O.
1
Australian National Clinical Evidence Taskforce
1
Calle Prieto, F. de la
1
Dalhat, M. et al.
1
Direction de Lutte contre la Maladie, Ministère de la Santé Publique, RD du Congo
1
European Centre for Disease Prevention and Control (ecdc)
1
Federal Ministry of Health - Nigeria Centre for Disease Contro
1
Federal Ministry of Health - Nigeria Centre for Disease Control
1
Federal Ministry of Health and Nigeria Centre for Disease Control
1
Graham,M.B.
1
H. Adler, Gould, S.
1
Hine, P.
1
Iroezindu, M.
1
Izibewule, J.H. et al.
1
Khalil, A.
1
Mauder, S.
1
MEDBOX
1
Medscape
1
Ministere de la santé et de la prévention, France
1
National Institute of Health, Pakistan
1
Ogoina, D.
1
Robert-Koch-Institut RKI
1
Saphra
1
The MEDBOX Team
1
UK Health Security Agency
1
Univ La Paz
1
Wasif Malik, M.
1
World Health Organization
1
Yinka-Ogunleye, A.
1
Publication Years
Category
Clinical Guidelines
33
Countries
4
Key Resources
2
Pharmacy & Technologies
2
Public Health
1
Women & Child Health
1
Ces recommandations temporaires sont émises à l’intention des États Parties qui font face à une transmission du virus de la mpox (MPXV), y compris, sans que cette liste soit exhaustive, ceux touchés par une transmission communautaire persistante et ceux où l’on observe des groupes de cas o... more
March 2025. Access to appropriate, quality-assured diagnostics remains a challenge. There is limited information on key characteristics of available test kits, including their performance, reliability, and ability to detect relevant Mpox clades. Additionally, the lack of multiplex diagnostic tools c... more
Register on the Website for free to receive the weekly briefing
Infographic
interim guidance, 25 November 2024
On 14 August 2024, the Director-General of the World Health Organization determined that the upsurge of mpox in a growing number of countries in Africa constitutes a new public health emergency of international concern (PHEIC) under the International Health Regulations (IHR) (2005)
30 July 2024
Patient's Guide
This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.
Issue Brief 39
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr... more
The monkeypox virus (MPXV) clade I epidemic that has been affecting the Democratic Republic of the Congo (DRC) since November 2023 has recently spread to several other African countries including Burundi, Rwanda, Uganda and Kenya. The size of these outbreaks could be larger than reported due to un... more
Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People ... more

Revised National Guidelines on Mpox

Wasif Malik, M.; et al. National Institute of Health, Pakistan (2024) CC
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
In conclusion, the current evidence does not support the use of mpox antigen RDTs in the field. More data are expected from independent evaluations conducted by Africa CDC, FIND or other organizations
Diagnostic de mpox.
On 13 August 2024, the Africa Centres for Disease Control (Africa CDC) declared the multi-country mpox outbreak a public health emergency of continental security, with strong recommendations to improve surveillance and vaccine deployment in all AU Member States. On 14 August 2024, the WHO Director-G... more
On 13 August 2024, the Africa Centres for Disease Control (Africa CDC) declared the multi-country mpox outbreak a public health emergency of continental security, with strong recommendations to improve surveillance and vaccine deployment in all AU Member States. On 14 August 2024, the WHO Director-G... more